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Increasing evidence suggests that ribosomes actively regulate protein synthesis. However,
much of this evidence is indirect, leaving this layer of gene regulation largely unexplored,
in part due to methodological limitations. Indeed, we review evidence demonstrating that
commonly used methods, such as transcriptomics, are inadequate because the variability in
mRNAs coding for ribosomal proteins (RP) does not necessarily correspond to RP variability.
Thus protein remodeling of ribosomes should be investigated by methods that allow direct
quantification of RPs, ideally of isolated ribosomes. We review such methods, with emphasis
on their biases and approaches to control these biases. We argue that using multiple comple-
mentary methods can help reduce the danger of interpreting reproducible systematic biases
as evidence for ribosome remodeling.
Introduction
The control of gene expression is crucial for all biological processes, from developmental stages
and homeostasis maintenance to regeneration processes. This regulation occurs at multiple lay-
ers, both transcriptional and post-transcriptional levels. Historically, transcription has been stud-
ied more extensively than translation, in large part because of the accessibility of technologies
for nucleic acid analysis. However, gene regulation via translation was appreciated as early as
the late 1960’s. For example, the production of insulin was linked to the increased number of
polysomes and protein synthesis [1]. Similarly, the synthesis of globin polypeptides (which forms
hemoglobin) was found to depend on heme, the oxygen-carrying iron-rich molecule in the blood
[2]. In the early 1980s, different aspects of early embryonic development, such as blastocyst
formation [3] and disparate patterns of protein synthesis [4] were linked to post-transcriptional
regulation. Key developmental genes, such as Oscar, are regulated at the level of translation and
spatial localization [5, 6]. Such post-transcriptional regulation is mediated at least in part by trans-
lational control mechanisms including RNA binding proteins, translation factors, and micro RNAs
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[7, 8].
In addition to these well-established mechanisms, increasing evidence suggests that ribosomes
may also regulate translation of mRNAs [9–14]. Ribosomes have long been viewed as passive
players in translation, with a fundamental role of catalyzing peptide-bond formation but exerting
regulatory effects only based on their availability [15, 16] and transnational control being exerted
by a teamwork of cis- and trans-regulators in which the interaction of mRNA structures and se-
quences worked with translation factors, RNA binding proteins, and microRNAs; the ribosome
complex was simply viewed as an effector of translation. However, ribosome-mediated regulation
through the alteration of ribosomal RNA and ribosomal proteins were both hypothesized [9, 11, 17]
and supported by mostly indirect evidence as recently reviewed by Emmott et al. [14]. Quantifica-
tion of ribosomal proteins from isolated ribosomes has begun to provide more direct evidence, as
mammalian ribosomes have been found to exhibit differential protein stoichiometry that depends
on the growth conditions and on the number of ribosomes per mRNA[18]. Such observations
suggest that different ribosome complexes may exist in order to fulfill disparate functions, which
can consequentially have regulatory effects on translation. This model, termed ribosome special-
ization, challenges the notion that ribosomes are static enzymes and instead introduces them as
active participants in post-transcriptional regulation. In this model, ribosomes could be specific
to distinct cell population and can affect the translation of mRNAs. The hypothesis of ribosome-
mediated translational regulation has been further supported by observations of differences in ribo-
somal protein composition occurring under stress [19–21] and cell differentiation[22–25]. Models
and observations linking different ribosomes to functional roles, such as immunoribosomes and
oncoribosomes, have suggested specific roles for specialized ribosomes, such as enhanced anti-
gen presentation [26, 27]. Localized synthesized RPs in the axon can also contribute to ribosome
remodeling [28, 29], suggesting possible roles of ribosome-mediated translational control in neu-
ronal functions. The possibility of ribosome specialization is further supported by the observations
that mutations of specific ribosomal proteins selectively affect the synthesis of specific proteins and
are strongly associated with distinct phenotypes such as cancer and aging [30, 31]. Such selectivity
suggests that ribosomes can regulate gene expression [10, 11, 14, 32].
Ribosomes in eukaryotes are made of about 80 core ribosomal proteins and four ribosomal
RNAs (rRNAs) [33]. The modifications of both molecular groups are important in the functionality
of the ribosome complex and are potential sources of ribosome heterogeneity and specialization
[34, 35]. Modifications of rRNA, such as methylation and pseudouridylation, which together span
a total of 7000 nucleotides, are known to stabilize the ribosome structure. Variant rRNA alleles
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and rRNA methylation may contribute to ribosomal specialization. In both mice and humans,
several rRNA sequence variants were identified and shown to exhibit tissue-specific expression;
furthermore, at least 23 percent of rRNA nucleotides are estimated to exhibit variant alleles within
the general human population [36]. On average, 32 variants were found to be expressed in single
individuals, while those sequence variants were found to significantly overlap with sequences that
are functionally important to ribosome function. The diversity of rRNA variants are thus suggested
to to have a biologically important role. Indeed, the methylation of the 16S rRNA at a specific
guanosine nucleotide revealed that this modification plays a role in controlling mistranslation and
could explain streptomycin-resistant phenotypes of M. tuberculosis [37]. Both rRNA and protein
modifications may contribute to ribosome specialization; The role of rRNA has been reviewed by
Mauro and Matsuda [38], and in this review we will focus on methods for investigating ribosome
specialization via modifications of the core ribosomal proteins.
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Figure 1 | Ribosomal proteins are under post-transcriptional control (a) A heatmap showing the levels of
ribosomal genes at the levels of RNA, ribosome density, and protein in lymphablastoid cells lines based on
data from Battle et al. [39]. The corresponding distribution of fold changes is shown to the right. (b) Protein
to mRNA ratios (PTRs) are quantified in two different human tissues; genes with significantly low p-values
are highlighted. Of interest, mRNAs coding for ribosomal proteins show contrasting behaviors, as those
PTRs are low in the stomach and high in the kidney. This panel is based on the analysis by Franks et al.
[40].
Post-transcriptional regulation of ribosomal proteins
While suggestive evidence for ribosome remodeling has originated from indirect methods (such as
measuring transcripts coding for RPs [41? ]), such data remain inconclusive because RP synthesis
and degradation are extensively regulated [39, 40, 42, 43]. RP molecules that are not incorporated
into a complex are rapidly degraded[42]. Because of this post-transcriptional regulation, analysis
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of ribosome remodeling in health and disease should rely on direct protein measurements. While
the abundance of RP transcripts are usually the most accessible data, these measures are indirect.
Consider, for example, the variability of RP transcripts, ribosome density, and ribosomal proteins
across a panel of lymphoblastoid cell lines shown in Fig. 1a. The data indicate substantial transcript
variability, which diminishes at the level of ribosome density and is almost absent for the ribosomal
proteins, Fig. 1a. Thus, variable RP transcripts do not necessarily indicate variable abundance
of RPs, Fig. 1a. More generally, the ratio between RPs and their corresponding transcripts can
vary substantially as shown in Fig. 1b for two tissues and observed in many other cases [40, 44].
Therefore, the levels of mRNAs coding for RPs are rather indirect evidence to support conclusions
about the protein composition of ribosomes.
To obtain more direct evidence for protein remodeling of ribosomes, one should directly mea-
sure RP abundances as a more direct approach for evaluating ribosome remodeling across different
conditions, Fig. 1a. Such analyses in cell lysates have suggested changes in the protein compo-
sition of ribosomes as budding yeast undergoes the diauxic shift [45], during aging [46, 47], and
upon LPS-stimulation of mouse dendritic cells[48]. In addition, RP analysis from cell lysates has
shown that ribosomal transcripts exhibit slower elongation rates with decreased protein production
relative to other transcripts with similar ribosome densities[49].
Although RPs are known to degrade very quickly when not incorporated into complexes[42],
RPs quantified in total cell lysates may originate in part from other extraribosomal complexes
[17, 50–54]. Excluding the influence of such extraribosomal complexes requires the analysis of
isolated ribosomes. The use of isolation methods, such as sucrose gradient fractionation or affin-
ity purification[55], prior to protein measurements provides an even more direct way to assess
ribosome remodeling in different conditions [18, 56, 57].
Precise and reproducible measurements may not be accurate
Since each method comes with its own potential for biases and systematic artifacts, the characteri-
zation of ribosome remodeling also calls for the use of complementary methods. A highly precise
method can offer consistently reproducible measurements that are also consistently biased. Repro-
ducibility does not necessarily correspond to accuracy. For example, RP levels estimated by GFP-
tagging and by Western blots differ significantly (Fig. 2a) despite the fact that replicates within
each method are reproducible [58, 59]. Generally, measurements can be affected by systematic bi-
ases, leading to technically reproducible but inaccurate measurements. Such data may consistently
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Figure 2 | Different methods provide different estimates of ribosomal protein abundance. A scatter plot com-
paring estimated abundance of ribosomal proteins from Western blots [58] and from flow cytometry analysis
of RPs tagged by green fluorescent protein (GFP)[59]. The Pearson correlation between the two estimates
is modest, ρ = 0.25
support an incorrect representation of the studied biological systems. The effect of biases is espe-
cially important to recognize when studying ribosome remodeling, since the changes of ribosomal
protein stoichiometry are often relatively small as observed in previous studies [18, 25, 60].
Analyzing ribosome remolding in individual cells
Ribosome remodeling is likely to contribute to the specialized proteomes of the diverse cell types
that arise during development and diverge to form different tissues [14]. Furthermore, cyclic tran-
scription of mRNAs coding for RPs suggests that ribosome biogenesis is highly temporarily or-
ganized and metabolically coordinate during the cellular life cycle [62–64]. While these possi-
bilities are of considerable interest, their investigation poses particular challenges for direct RP
quantification by complementary methods [65, 66]. These challenges stem from the difficulty of
quantifying proteins in tissues comprised of heterogeneous cells. Single-cell proteomics has ap-
proached this question in the context of embryonic stem cells differentiating to epiblast lineages
in embryoid bodies [61]. In this system, the correlations among RPs (Fig. 3) revealed one large
and one small cluster, suggesting that the RPs from the small cluster covary in a cell-type specific
manner. However, these data have not been cross-validated by independent methods and thus re-
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Figure 3 | Covariation of ribosomal proteins across diverse single cells Pairwise correlations between RPs
computed from protein measurements in individual differentiating stem cells [61]. The correlation matrix
was clustered based on the cosine between the correlation vectors.
main inconclusive. Nonetheless, advances in single-cell proteomics hold the potential to increase
the reliability of single-cell protein analysis and to enable cross-validation of such measurements
[65–68]. Thus these technological advances may soon enable direct examination of ribosome spe-
cialization within the diverse cell types that comprise different tissues.
The need for complementary methods
The technical biases of each method type are challenging to overcome, but the use of comple-
mentary methods with divergent weaknesses can help guard against systematic artifacts. Thus, the
use of complementary techniques allows for both the attainment of strong evidence for ribosome
remodeling and the cross-validation of results that can support more confident conclusions. As an
example, RPs from isolated ribosomes may be quantified separately by both mass spectrometry
and Western blots and then the results can be compared as shown in Fig. 4. The measured RP dif-
ferences delivered from these two disparate methods are highly similar, indicating that the results
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are likely to be driven by biological effects rather than the inherent biases. More broadly, if biases
were the main force behind the results, the outcomes would have been presumably different; thus,
the more different the methods, the less likely they are to share biases, and the more beneficial they
are in being used together as complementary methods.
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Figure 4 | Quantifying ribosomal proteins with complementary methods (a) Polysomal enrichment of RPs quan-
tified by mass-spectrometry using isobaric mass tags [18]. Using either trypsin or Lys-C to digest the RPs provided
consistent estimates that were combined [18]. The panel is reproduced from Slavov et al. [18]. (b) Polysomal enrich-
ment of RPs quantified by Western blots [18]. RPs were quantified by Western blots in monosomes and polysomes
from E14 mouse ESCs. Rpl32 was used as a loading control and the boxplots summarize data from 9 ratios for each
quantified RP. The panel is reproduced from Slavov et al. [18].
Direct quantification of RPs with complementary methods (as shown in Fig. 4) can reveal
changes in the ribosome complex that may contribute to post-transcriptional regulation of gene
expression [18]. Mass spectrometry (MS) offers an array of such complementary approaches
for discovering and validating ribosome remodeling. These powerful methods directly measure
protein or peptide abundance, either through relative or absolute quantification, and can provide
information about the stoichiometry of the ribosome complex along with modifications of the ri-
bosomal proteins. These results can be enhanced and cross-validated by structural methods, such
as X-ray crystallography and cryogenic electron microscopy (cryo-EM). These latter methods can
directly probe the arrangement of ribosomal proteins within the complex. In this review, we dis-
cuss the types of biases, limitations, and advantages associated with each approach type, focusing
particularly on the investigation of ribosome remodeling.
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Quantifying ribosomal proteins via mass spectrometry
The levels of ribosomal protein expression can be directly measured using mass spectrometry pro-
teomics. Whole proteins, or even entire ribosome complexes can be evaluated through top-down
mass spectrometry [69, 70]. However, because MS analysis of full length proteins is technolog-
ically challenging, it is more common to first digest proteins into peptides and then analyze the
peptides by MS. This latter approach is known as bottom-up mass spectrometry, which involves
the caveat that the protein levels need to be inferred from digested peptides. These two branches
(top-down and bottom-up) of mass spectrometry can be implemented by many methodologies,
each of which has systematic biases and can directly quantify RP stoichiometry across biological
conditions.
Top-down and bottom-up proteomics methods can be viewed as complementary measurements,
as they analyze and quantify proteins and peptides in inherently different ways. Methods within the
respective branches can also be considered as complementary, and thus can help detect and mitigate
biases. Technical biases that can affect the ultimate biological interpretation of any experiment can
be potentially introduced at any step of the proteomics pipeline, from sample preparation to MS
analysis. These distinct biases can be controlled by different methods in contrasting ways and to
varying extents. Thus the ability to co-validate results methods that measure RPs in disparate ways
increases our assurance that observed ribosomal protein changes are induced not artificially but
biologically.
Biases in bottom-up mass spectrometry
Bottom-up proteomics can be implemented by many methods, all of which have caveats, specifi-
cally for quantifying ribosomal proteins. The amount of ribosomes in most cells is generally quite
ample, with as many as 10 million in a mammalian cell. Even so, the sequences of ribosomal
proteins are rather short, with a median length of about 133 amino acids in human cells, in stark
contrast to the overall proteome sequence length, which is 375 amino acids. Thus, ribosomal pro-
teins tend to produce fewer peptides during digestion. In addition, ribosomal proteins are likely
to produce shorter peptides when using trypsin, the most commonly used protease, due to a large
number of arginine (R) and lysine (K) amino acids present in the protein sequences [71]. The
over representation of K and R may contribute to a higher miscleavage rate, which can complicate
analyses. These downsides can be taken into account by the use of multiple alternative proteases
such as Lys-C and Glu-C in order to cross-validate results with the commonly used protease of
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trypsin [72, 73]. These biases can be very significant when estimating absolute protein abundances
(due to differences in peptide flyability, a collective term describing efficiency of ionization and
detection), and these biases may cancel out in relative protein quantification [74, 75].
Quantifying protein stoichiometry by bottom-up mass spectrometry
The differences in peptide flyability and other peptide specific biases poise a major challenge to
quantifying stoichiometry (ratios) between different proteins and their proteoforms [74, 76]. In-
deed, a peptide might be more intense because it is delivered more efficiently to the MS analyzer
rather than because it originates from a more abundant protein. These peptide specific biases cancel
out when performing relative quantification of a protein across different samples. This idea of can-
celing out biases can be extended by first-principle models, such as HIquant, to allow quantifying
stoichiometry between different proteins independent from peptide specific biases [75]. Such an
approach is likely to be particularly fruitful for quantifying RP preforms originating from different
prologues, alternative splicing events or post-translational modifications [14, 75, 77].
In bottom-up proteomics, digested peptides are separated via liquid chromatography (LC) and
ionized through electrospray ionization (ESI) or matrix-assisted desorption/ionization (MALDI).
Then, these peptides are introduced into the mass spectrometer as precursor ions, which can be
used for direct quantification or can be further isolated and disintegrated into fragment ions that are
then used for sequence identification and quantification. Bottom-up MS may either simultaneously
isolates and fragments multiple peptides in parallel (known as DIA; data independent acquisition)
or analyze a single peptide at a time (known as DDA; data dependent acquisition). DDA methods
were introduced in 1990s and have been widely used for decades [78, 79]. DIA was introduced
later (2004) by Yates and colleagues [80] and has matured into methods that offer the advantage
of parallel analysis and afford identifying and quantifying many thousands of peptides in a single
run [81, 82].
Quantification of peptides can be based directly on precursor ions (MS1-based) or fragment
ions (MS2-based). Both of these peptide quantification approaches can be implemented by mul-
tiple methods. These methods differ in the way and extent to which they control technical biases
stemming from the proteomics pipeline, which can be viewed as two main groups: sample prepa-
ration procedures and LC-MS analysis. Wet-lab procedures encompass the experimental steps of
isolating ribosomes from cell lysates, protein digestion into peptides, and various labeling tech-
niques. In LC-MS analysis, biases can be introduced due to differential peptide separation, ioniza-
tion, and isolation for MS2 analysis. The available bottom-up methods control for these technical
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biases at different stages. Due to the disparities in biases, different bottom-up approaches can be
viewed as highly complementary techniques. The complementary nature allows us to gain more
confidence in results showing biological changes, especially in ribosome remodeling where the
changes may be small.
Control of biases at the MS1-Level of Peptide Quantification
Methods that use the MS1 level in order to quantify peptides can be classified either as labeled
or label-free approaches. The label-free approaches are attractive for their simplicity and fewer
experimental steps. In these methods, each sample undergoes the sample preparation and mass
spectrometry analysis separately. In contrast, labeled techniques allow analyzing multiple samples
in parallel and thus more opportunities to control for biases that occur during the parallel stages.
Labeling approaches for MS1-based quantification include: SILAC (Stable Isotope Labeling of
Amino Acids in Cell Culture), dimethyl labeling, and mTRAQ. SILAC introduces sample label-
ing to living cells during protein synthesis through the metabolic labeling of newly synthesized
proteins[83]. Essentially, cells are incubated in cell culture medium that contains stable-isotope
enriched amino acids, usually arginine and lysine [84, 85], which are then incorporated into new
proteins. Dimethyl labeling, on the other hand, introduces sample labeling after digestion. This
chemical labeling approach relies on the reaction between formaldehyde and sodium cyanoboro-
hydride with lysine side chains and N-terminal primary amines in order to form dimethylamines
[86, 87]. mTRAQ quantification, which also introduces labels after digestion, was designed specif-
ically for targeted MS, in which specific peptides found in previous shotgun runs could be probed
[88, 89].
Biases can be introduced at every step of the proteomics pipeline and can be controlled through
mixing the samples as early in the experimental pipeline as possible. The earlier the samples
are combined together, the sooner the samples can be exposed to identical conditions and the
sooner the biases can be controlled. Among the available MS methods, SILAC allows mixing of
samples earliest, even prior to ribosome isolation and MS procedures, thus enabling the control of
all biases associated with these experimental and MS steps. This is especially advantageous when
studying subcellular fractions, such as the ribosome complex. Labeling methods allows the mixing
of samples prior to LC separation and MS analysis, which controls for LC- and MS-related biases,
while label-free methods will not control for these biases, as each sample is analyzed individually.
Technical biases leading to artifacts are potentially introduced during liquid chromatography
peptide separation and mass spectrometry analysis, which MS1-based labeling methods can con-
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trol but label-free cannot. Each run in the mass spectrometer is subject to a host of variable factors
that might influence measured ion intensities, including variability in peptide separation, ioniza-
tion, and instrumentation. This can cause different runs to experience drifts in retention time and
m/z, leading to complicated analyses. Ion suppression, a complicated phenomenon that affects the
final amount of charged ions that ultimately reaches the detector, can also undermine quantitative
accuracy. In the cases of labeling, digested peptides from each sample are separated, ionized, and
analyzed together, allowing for the samples to experience the same nuances due to each of those
steps. Label-free approaches in particular suffer from the fact that large portions of peptides are
not detected in every sample, which is termed as the missing value problem[90]. This problem
makes it more difficult to compare RP abundance across different conditions. Advances relying on
matching peptide intensity readouts, i.e. MaxLFQ[91], and on enhanced peptide identifications via
DIA [80–82] or DDA methods incorporating retention time information [66, 92, 93] can mitigate
the missing value problem.
While labeling methods allow controlling for biases during peptide separation and ionization,
labeling itself can introduce biases, limitations, and artifacts. All labeling approaches may be ad-
versely affected by incomplete labeling, and thus the completeness of labeling should be part of
the quality control. The time to fully label a biological system of interest can take days to weeks
when using SILAC, while the dimethyl labeling step is quite fast (around 5 minutes) and is highly
cost-effective, as the reagents are inexpensive [94]. Because dimethyl labeling is performed after
digestion, it can be used for any cell line or tissue not amenable to the metabolic labeling tech-
nique of SILAC. More specifically, the introduction of heavy isotopes into live cells and animals
can induce unintended growth changes[95, 96] and may even affect behavioral characteristics of
mice[97, 98]. Also, depending on the model system used, the potential conversion of arginine to
proline may lead to underestimation of heavy-labeled peptides[99]. On the other hand, dimethyl
labeling has been associated with a loss of hydrophillic peptides[100], which can lead to fewer
overall peptide identifications.
MS1-based quantification techniques also have limitations that are shared among all methods.
A disadvantage of MS1-based labeling methods is that the number of multiplexed samples is usu-
ally limited to 2 or 3. As the number of isotopically labeled samples increases, so does the number
of precursor ions in MS1 scans. The high density of ions may lead to interference between coelut-
ing ions with very similar m/z ratios. The use of NeuCode metabolic labeling offers higher SILAC
multiplicity through the use of labels that differ in mass on the scale of milli-Daltons[101, 102];
thus, this technique requires higher resolving power of the mass analyzers [101, 102]. Because
11
of the inherent limitations that MS1-level methods present, it is important to consider using com-
plementary methods rather than multiple technical replicates of just one method type. MS1-based
methods can be co-validated with MS2-based approaches, which still come with their own biases;
however, the set of biases derived from both quantification approaches are different. Thus, the
level of complementarity is high, allowing for increased confidence in quantifying even small RP
changes.
Control of biases at the MS2-Level of Peptide Quantification
After isolation, precursor ions are fragmented, and the resulting (fragment) ions analyzed by an-
other (MS2) scan. In most cases, MS2-based quantification is used with isobaric tags, such as tan-
dem mass tags (TMT)[103] or Isobaric Tags for Relative and Absolute Quantification (iTRAQ)[104,
105]. DIA analysis can also benefit from incorporating MS2-level data in order to improve the ac-
curacy of label-free quantification [106].
With isobaric labeling, peptides of each sample are covalently labeled with a sample-specific
mass tag. Mass tags are comprised of a reporter ion, a balance group and a reactive group, which
is usually an amine reactive group (NHS group) that binds to primary amines from the peptides.
After labeling, the samples are mixed together, allowing the analysis multiple samples (up to 16
with TMT Pro) in a single mass spectrometry run. Thus, the multiplexed samples undergo ion-
ization and ion selection for MS2 analysis together, greatly mitigating the missing value problem.
Additionally, the multiplexing permits analyzing more samples per unit time. Another advantage
is that the number of precursor ions detected during MS1 scans does not increase with the number
of samples, as each isobaric tag has an identical mass which allows a particular peptide from differ-
ent samples to appear as a single feature in the ion map defined by retention times and m/z ratios.
Peptides from different samples are thus indistinguishable at the MS1 level. Upon isolation and
fragmentation of precursor ions, they release distinct reporter ions and peptide fragments, some
of which remain bound to the balance group. Since the reporter ions and the balance groups have
sample-specific number of heavy isotopes, they allow for the ratiometric quantification of samples.
Since all peptide from a sample release the same reporter ion upon fragmentation, the accuracy
of quantifying a peptide from its reporter ions is dependent on isolating only its precursor ion for
subsequent fragmentation and MS2 analysis. In practice, the MS2 scan typically also contains
coisolated peptides. The degree of coisolation can be estimated and used to remove peptides with
unacceptably high coisolation. Narrower isolation windows [67] and sampling elution peaks at
their apexes [107] reduce coisolation but may not completely eliminate it. When multiple peptide
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precursors are coisolated for fragmentation, the measured reporter ion intensities are proportional
to the superposition of peptide abundances, which results in inaccurate quantification and generally
compressed peptide ratios. However, ratio compression is not necessarily due to coisolation since
it may be caused by other factors, such as unintentional cross-labeling or sample carry-over on
the LC column. Coislation can be reduced by subjecting fragment ions to further isolation and
fragmentation steps by taking MS3 or even higher scans[108]. This MS3 approach reduces the
number of analyzed ions and thus diminishes the sensitivity and the throughput of the analysis. A
second option for reducing biased due to coisolation is to use the peptide fragments with attached
balance groups, which are termed complement ions[109]. These complement ions are produced
during the fragmentation step as a result of the mass balance group remaining attached to the
peptide or its fragments, and thus they can be specific to the analyzed peptide.
Abundant peptides, such as those originating from RPs, tend to be less affected by coisolation
since the majority of the reporter ions used for quantification will be derived from the abundant
peptides. However, coisolation can still contribute significant bias to RP quantification and thus
necessitates quality controls. One way to benchmark data quality is through the calculation of the
agreement of different peptides originating from the same protein. Ribosomal peptides that origi-
nate from a RP should indicate consistent quantification of the protein; The degree of consistency
can be quantified by measures such as reliability or coefficients of variation [40].
The methods of quantifying peptides at either the MS1 or MS2 levels come with inherent bi-
ases that might complicate analyses and may present reproducible results that are actually artifacts
induced from systematic biases. However, the set of biases for each method type is different, and
thus different methods may complement each other. Instead of choosing just one mass spectrom-
etry method to identify changes of ribosomal proteins, methods that differ as much as possible
(such as MS1 and MS2 based quantification) or non mass-spec methods should be used in parallel
(as shown in Fig. 4) so that the results can be co-validated.
Top-down mass spectrometry
With top-down proteomics[69, 70], whole ribosomal proteins or even whole ribosomes can be
analyzed, offering an more intact picture of the ribosome and potential characterization of prote-
oforms and post-translational modifications (PTMs). These methods identify the full amino acid
sequence of a protein including modifications and thus do not require protein inference from pep-
tides. However, these techniques are more more challenging because compared to peptides, pro-
teins are more difficult to solubilize, separate, ionize and sequence [110]. These challenges result
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in lower sensitivity and throughput of the analysis, as well as higher technical requirements from
the instruments for high resolving power at high m/z ratios [111–113]. Nonetheless, these chal-
lenges are rapidly being addressed by innovative methods for protein separation (such as capillary
zone electrophoresis [114]), sensitive methods allowing the detection of individual ions [115, 116],
and by community standards [117].
The biases associated with either bottom-up or top-down proteomics are very different, which
presents opportunities for combining them synergistically. The hybrid combination of mass spec-
trometry techniques has been used to characterize whole ribosome complexes by quantifying RP
levels along with proteoforms [112]. Such an approach has offered novel observations about cys-
teine modification of RPS27, and ribosome assembly sites through the characterization of ribo-
somes originating from human, plant, and bacterial cells [118]. Additionally, the elusive ribosomal
protein SRA was successfully quantified and found to have heterogeneous stoichiometry in E. coli
ribosomes [112].
Complementary structural biology techniques
We have focused our review on the higher throughput MS methods, but many structural biology
methods can provide more detailed information about ribosome modifications and structure albeit
at lower throughput. These include chemical cross linking of proteins [119, 120], X-ray diffraction,
and cryo-EM. The analysis of both protein sequence in tandem with spatial information allows not
only to co-validate results ribosome remodeling observations but also to start revealing its func-
tional significance. Such a combined approach has been used to study other complexes, such as
the human nuclear pore complex scaffold [121], bacteriophage portal complexes[122], 26S pro-
teasome complex[123] and COPII vesicles that transport proteins to the Golgi apparatus from the
endoplasmic reticulum [124]. In fact, such combination of structural biology and mass spectrom-
etry has been used to study a particular subcomplex involved in ribosome biogenesis [125, 126].
The synergy between these methods can help identify specialized ribosomal structures and confir-
mations regulating protein synthesis.
X-ray diffraction requires the crystallization of the sample of interest prior to analysis, while
cryo-EM eliminates this need. The process of crystallization can demand much optimization,
which can involve the purification of many ribosomes. The obviation of crystallization allows
for the study of more kinds of ribosomes without the limitation of crystallizing them. The flash-
freezing of samples allows the observation of molecules in a ”near-native” state; since molecules
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are not constrained to a crystal, they have more degrees of freedom, thus allowing for more con-
formational states to be studied. However, cryo-EM studies can require anywhere from hundreds
to thousands single particle images, which involves long hours of image acquisition at the mi-
croscope. Furthermore, many of these images are discarded due to the phenomenon known as
beam-induced motion, which produces blurred images [127]. Despite limitations, both technique
types continue to reveal the ribosome protein structure. Recently, X-ray diffraction was used to
discover the role of potassium ions within the ribosome on the stabilization of the protein complex
in both the initiation and elongation states of translation [128]. Cyro-EM has been nearing the
sensitivity and resolution of X-ray diffraction, as seen through the report of the entire bacterial
ribosome resolved at two angstroms [129].
The synergy of mass spectrometry and structural biology techniques can empower novel ob-
servations of the ribosome complexes. These method types are different in terms of sample prepa-
ration and measurement acquisition, yet are complementary in the type of information that is pro-
vided. Combining protein composition information with conformational changes can help reveal
different roles of ribosomes within protein synthesis, and ultimately gene expression. Such knowl-
edge can help decipher the degree of ribosome remodeling during normal development and phys-
iology (e.g., immunoribosomes) and during diseases (e.g., oncoribosomes). The combination of
mass spectrometry with structural biology has been used to elucidate several facets of the ribo-
some complex subunits, including ribosome assembly in bacteria[125, 130, 131] and the effect of
dimerization on ribosomes when nutrients are scarce [132]. In addition, ribosome remodeling has
been found to occur in the bacterial ribosome through the use of MS and X-ray crystallography
[133].
Reliable quantification of ribosome remodeling is a challenging endeavor as evident from the
reviewed examples. Mass spectrometry presents direct and high-throughput approaches to as-
sess ribosomal protein remodeling. However, as discussed in this review, each mass spectrome-
try method comes with caveats and limitations, and many introduce systematic biases. To guard
against such biases, complementary methods should be synergistically combined. Such combined
approach can propel highly efficient and reliable investigation of ribosome modeling and its func-
tional impact in health and disease.
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